Eisai Pharma announces its plans to set up GCC in Vizag
Expanding its digital transformation and innovation footprint in India, the announcement was made by Makoto Hoketsu, Global Chief Information Officer of Eisai Pharma, during his visit to GITAM Deemed to be University on Wednesday.
Hoketsu, accompanied by his core technical team, interacted with Visakhapatnam Member of Parliament and GITAM's president M Sribharat.
Speaking on the occasion, Makoto Hoketsu emphasised the company's commitment to accelerating digital transformation initiatives with robust support from the Government of Andhra Pradesh and the Visakhapatnam Special Economic Zone (VSEZ).
'By bringing together exceptional digital talent, we aim to drive cutting-edge solutions that redefine how healthcare meets evolving needs,' said Hoketsu. He lauded the institution's academic infrastructure, its thriving interdisciplinary research environment, and the emphasis on emerging technologies. Expressing strong interest in academic collaboration, he noted that GITAM could become a valuable partner in Eisai's mission to integrate digital innovation in healthcare.
During the interaction, Sribharat highlighted the institution's strategic focus on industry partnerships, innovation-driven education and real-world research. 'We are keen to explore joint research activities and collaborative technology development in areas such as data science, healthcare technologies, and pharmaceutical research with Eisai Pharma,' he stated.
Institution's secretary M Bharadwaja, Vice-Chancellor Dr Eroll D'Souza, Pro Vice-Chancellor Prof Y Goutham Rao, Dean of Computer Science Arun Kumar, head of MURTI Labs Dr B V R Tata, and Director of IT Wing V Sairam, along with other senior faculty members were present.
Try Our AI Features
Explore what Daily8 AI can do for you:
Comments
No comments yet...
Related Articles
United News of India
a day ago
- United News of India
Asia is playing an integral role in the Global GDP: OECD Report
New Delhi, July 11 (UNI) The Organization for Economic Co-Operation and Development (OECD) has highlighted the growing Asian economy behind driving the global Gross Domestic Product or GDP to a major extent. The OECD is a global organization that aims to promote policies for economic and social well-being across the world. Reportedly, the Asian economy contributes to almost 31% of the Global GDP, and the vibrant region is home to approximately 55% of the world's premier companies. Asia is playing a great role in public equity markets, especially for the growth-hungry companies. While other major areas of the Asian capital markets remain underdeveloped and struggling to join the mainstream economic line. Despite the fueled market-based financing in the Asian region, corporate financing in multiple Asian countries is still linked to banks, with a high share of credit value to the banks. UNI SAS GNK 2004 Tags: #Asia is playing an integral role in the Global GDP: OECD Report
Time of India
2 days ago
- Time of India
Eisai pharma to set up global capability center in Vizag
Visakhapatnam : Eisai Pharma, a noted human health care pharmaceutical company, announced its plans to establish a new global capability center (GCC) in Visakhapatnam, further expanding its digital transformation and innovation footprint in India. The announcement was made by Makoto Haketsu, global chief information officer of Eisai Pharma, during his visit to Gitam Deemed to be University on Wednesday. Haketsu, accompanied by his core technical team, interacted with Vizag MP and GITAM president M Sribharat, who led the university's leadership team in hosting the delegation. The discussions centered around potential academic-industry collaborations and aligning digital healthcare initiatives with research and innovation. Speaking on the occasion, Makoto Haketsu explained the company's commitment to accelerating digital transformation initiatives with robust support from the AP govt and the Visakhapatnam Special Economic Zone. "By bringing together exceptional digital talent, we aim to drive cutting-edge solutions that redefine how healthcare meets evolving needs," said Haketsu. Expressing strong interest in academic collaboration, he noted that GITAM could become a valuable partner in Eisai's mission to integrate digital innovation in healthcare. by Taboola by Taboola Sponsored Links Sponsored Links Promoted Links Promoted Links You May Like Villas For Sale in Dubai Might Surprise You Dubai villas | search ads Get Deals Undo During the interaction, Vizag MP Sribharat highlighted GITAM's focus on industry partnerships, innovation-driven education, and real-world research. "We are keen to explore joint research activities and collaborative technology development in areas such as data science, healthcare technologies, and pharmaceutical research with Eisai Pharma," he said. Eisai's visiting delegation also included Eisai India executive director & site head (VSP) Dr Girish Dixit, deputy senior executive director (IT) Kosuke Ichinose, talent management lead Naonori Shibata, chief operational excellence officer Dr Kentaro Nagane, human resource head Dr Hemant Nikam, projects & engineering head Anand Gal Phade and IT head Joseph Kiran Kumar.
Hans India
3 days ago
- Hans India
Eisai Pharma announces its plans to set up GCC in Vizag
Visakhapatnam: Eisai Pharma, a noted human health care pharmaceutical company with a global presence, announced its plans to establish a new Global Capability Center (GCC) in Visakhapatnam. Expanding its digital transformation and innovation footprint in India, the announcement was made by Makoto Hoketsu, Global Chief Information Officer of Eisai Pharma, during his visit to GITAM Deemed to be University on Wednesday. Hoketsu, accompanied by his core technical team, interacted with Visakhapatnam Member of Parliament and GITAM's president M Sribharat. Speaking on the occasion, Makoto Hoketsu emphasised the company's commitment to accelerating digital transformation initiatives with robust support from the Government of Andhra Pradesh and the Visakhapatnam Special Economic Zone (VSEZ). 'By bringing together exceptional digital talent, we aim to drive cutting-edge solutions that redefine how healthcare meets evolving needs,' said Hoketsu. He lauded the institution's academic infrastructure, its thriving interdisciplinary research environment, and the emphasis on emerging technologies. Expressing strong interest in academic collaboration, he noted that GITAM could become a valuable partner in Eisai's mission to integrate digital innovation in healthcare. During the interaction, Sribharat highlighted the institution's strategic focus on industry partnerships, innovation-driven education and real-world research. 'We are keen to explore joint research activities and collaborative technology development in areas such as data science, healthcare technologies, and pharmaceutical research with Eisai Pharma,' he stated. Institution's secretary M Bharadwaja, Vice-Chancellor Dr Eroll D'Souza, Pro Vice-Chancellor Prof Y Goutham Rao, Dean of Computer Science Arun Kumar, head of MURTI Labs Dr B V R Tata, and Director of IT Wing V Sairam, along with other senior faculty members were present.
